SE9300139L - Framställning av ett nytt läkemedel - Google Patents

Framställning av ett nytt läkemedel

Info

Publication number
SE9300139L
SE9300139L SE9300139A SE9300139A SE9300139L SE 9300139 L SE9300139 L SE 9300139L SE 9300139 A SE9300139 A SE 9300139A SE 9300139 A SE9300139 A SE 9300139A SE 9300139 L SE9300139 L SE 9300139L
Authority
SE
Sweden
Prior art keywords
sulphate
pylori
protein
prophylaxis
heparin
Prior art date
Application number
SE9300139A
Other languages
Unknown language ( )
English (en)
Other versions
SE9300139D0 (sv
Inventor
Olle Larm
Torkel Wadstroem
Original Assignee
Medicarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb Ab filed Critical Medicarb Ab
Priority to SE9300139A priority Critical patent/SE9300139L/sv
Publication of SE9300139D0 publication Critical patent/SE9300139D0/sv
Priority to PCT/SE1994/000021 priority patent/WO1994016714A1/en
Priority to AU58944/94A priority patent/AU5894494A/en
Publication of SE9300139L publication Critical patent/SE9300139L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SE9300139A 1993-01-19 1993-01-19 Framställning av ett nytt läkemedel SE9300139L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9300139A SE9300139L (sv) 1993-01-19 1993-01-19 Framställning av ett nytt läkemedel
PCT/SE1994/000021 WO1994016714A1 (en) 1993-01-19 1994-01-14 The use of a composition for the treatment of infections caused by helicobacter pylori
AU58944/94A AU5894494A (en) 1993-01-19 1994-01-14 The use of a composition for the treatment of infections caused by helicobacter pylori

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300139A SE9300139L (sv) 1993-01-19 1993-01-19 Framställning av ett nytt läkemedel

Publications (2)

Publication Number Publication Date
SE9300139D0 SE9300139D0 (sv) 1993-01-19
SE9300139L true SE9300139L (sv) 1994-07-20

Family

ID=20388583

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9300139A SE9300139L (sv) 1993-01-19 1993-01-19 Framställning av ett nytt läkemedel

Country Status (3)

Country Link
AU (1) AU5894494A (sv)
SE (1) SE9300139L (sv)
WO (1) WO1994016714A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE518597C2 (sv) * 1994-05-04 2002-10-29 Medicarb Ab Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies
TR199900940T2 (xx) * 1996-10-28 1999-09-21 Astra Aktiebolag Helikobakter pilori ile ilgili n�kleik ve amino asit sekanslar�.
EE9900226A (et) * 1996-12-05 1999-12-15 Astra Aktiebolag Helicobacter pylori'ga seotud nukleiinhapete ja aminohapete järjestused ning nende vaktsiinikompositsioonid
SE508760C2 (sv) 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
AU3731399A (en) * 1998-06-09 1999-12-30 Ghen Corporation Fixation inhibitors for (helicobacter pylori)
CN102641496A (zh) 2011-02-16 2012-08-22 辛绍祺 高分子聚合物的新用途及其组成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116821A (en) * 1990-11-20 1992-05-26 The Procter & Gamble Company Sulfated glyceroglucolipids as inhibitors of bacterial adherence
IT1249060B (it) * 1991-05-24 1995-02-11 Bononi Ricerca Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.

Also Published As

Publication number Publication date
WO1994016714A1 (en) 1994-08-04
AU5894494A (en) 1994-08-15
SE9300139D0 (sv) 1993-01-19

Similar Documents

Publication Publication Date Title
EP0835315A4 (en) PIG RESPIRATORY DYSGENESIS SYNDROME VACCINE
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
NO20003716D0 (no) Protein D for anvendelse in vitro, renset antistoff som binder proteinet, samt anvendelser derav
ATE371373T1 (de) Durch polynukleinsäuren vom reproduktiven und respiratorischen syndromvirus des schweines kodierte proteine
DE69122240D1 (de) Antigen-wirkende proteine von borrelia burgdorferi
SE9300139L (sv) Framställning av ett nytt läkemedel
KR900013983A (ko) 콕시디오시스 왁찐
EP0675728A4 (en) MEANS AND METHODS FOR IMPROVING KERATINOYCTE ADHESION TO THE SKIN.
DE3855442D1 (de) Verfahren zur Gewinnung von Schutzantigenen gegen Bordetella-Infektionen und toxische Prozesse
Homan et al. Identification of diagnostic antigens from Trichinella spiralis
Stinson et al. Binding of streptococcal antigens to muscle tissue in vitro
Brandtzaeg Human secretory component—IV. Aggregation and fragmentation of of free secretory component
IL90281A0 (en) Igm containing anti-bacterial compositions
PT93178A (pt) Agente proteico anticanceroso
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
SE9500418L (sv) Nya försvagade Pseudomonas aerugionos stammar
AU3718784A (en) Antibodies and antibody containing compositions for inhibiting gingivitis
DK592086A (da) Humant conglutinin
Ingram et al. Serum protein changes in brown trout (Salmo trutta L.) after single injections of soluble and cellular antigens
KR890700133A (ko) 인체단일클론항체 및 그것을 활성성분으로 함유하는 감염증의 예방 및 치료제
Minta et al. Chemical and immunological characterization of the electrophoretic components of the Fc fragment of human immunoglobulin G
PT87001A (pt) Processo para a preparacao de uma vacina contra a disenteria suina e fins analogos
Hudson et al. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens
SE7904276L (sv) Renat cancerassocierat protein
KR900013985A (ko) 녹농균에 대한 반응성을 갖는 사람 모노클로널항체

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9300139-4

Format of ref document f/p: F